feed,title,long_url,short_url
Benzinga,"Johnson & Johnson Beats Q3 Estimates Led By Strength From Cancer, Crohn's Disease Drugs, Tightens Guidance",https://benzinga.com/general/biotech/22/10/29301977/johnson-johnson-beats-q3-estimates-led-by-strength-from-cancer-crohns-disease-drugs-tightens-guid,https://bit.ly/3D5jnBp
